Joanna A. Krupka
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).
Journal: Blood
Published: April 10, 2026
Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 19, 2026
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 22, 2025
Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the Challenge.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 19, 2022
SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independence.
Journal: Blood
Published: December 15, 2020
Genetic modification of primary human B cells to model high-grade lymphoma.
Journal: Nature communications
Published: April 15, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026